215 related articles for article (PubMed ID: 24333978)
1. [Evaluation of thrombocytosis as predictive factor in colorectal cancer].
Baranyai Z; Jósa V; Krzystanek M; Eklund AC; Szász AM; Szállási Z
Magy Seb; 2013 Dec; 66(6):331-7. PubMed ID: 24333978
[TBL] [Abstract][Full Text] [Related]
2. The comparison of thrombocytosis and platelet-lymphocyte ratio as potential prognostic markers in colorectal cancer.
Baranyai Z; Krzystanek M; Jósa V; Dede K; Agoston E; Szász AM; Sinkó D; Szarvas V; Salamon F; Eklund AC; Szállási Z; Jakab F
Thromb Haemost; 2014 Mar; 111(3):483-90. PubMed ID: 24285160
[TBL] [Abstract][Full Text] [Related]
3. Elevation of platelet count in patients with colorectal cancer predicts tendency to metastases and poor prognosis.
Lin MS; Huang JX; Zhu J; Shen HZ
Hepatogastroenterology; 2012 Sep; 59(118):1687-90. PubMed ID: 22591645
[TBL] [Abstract][Full Text] [Related]
4. Relationship of postoperative thrombocytosis and survival of patients with colorectal cancer.
Josa V; Krzystanek M; Eklund AC; Salamon F; Zarand A; Szallasi Z; Baranyai Z
Int J Surg; 2015 Jun; 18():1-6. PubMed ID: 25843227
[TBL] [Abstract][Full Text] [Related]
5. Thrombocytosis of Liver Metastasis from Colorectal Cancer as Predictive Factor.
Jósa V; Krzystanek M; Vass T; Lang T; Juhász V; Szilágyi K; Tihanyi B; Harsányi L; Szállási Z; Salamon F; Baranyai Z
Pathol Oncol Res; 2015 Sep; 21(4):991-7. PubMed ID: 25761795
[TBL] [Abstract][Full Text] [Related]
6. Impact of preoperative thrombocytosis on the survival of patients with primary colorectal cancer.
Sasaki K; Kawai K; Tsuno NH; Sunami E; Kitayama J
World J Surg; 2012 Jan; 36(1):192-200. PubMed ID: 22045447
[TBL] [Abstract][Full Text] [Related]
7. Poor Prognosis Significance of Pretreatment Thrombocytosis in Patients with Colorectal Cancer: a Meta-Analysis.
Zhao JM; Wang YH; Yao N; Wei KK; Jiang L; Hanif S; Wang ZX
Asian Pac J Cancer Prev; 2016; 17(9):4295-4300. PubMed ID: 27797233
[TBL] [Abstract][Full Text] [Related]
8. Preoperative thrombocytosis is associated with survival after surgery for colorectal cancer.
Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Kubota K
J Surg Oncol; 2012 Dec; 106(7):887-91. PubMed ID: 22623286
[TBL] [Abstract][Full Text] [Related]
9. A new prognostic model for cancer-specific survival after radical cystectomy including pretreatment thrombocytosis and standard pathological risk factors.
Todenhöfer T; Renninger M; Schwentner C; Stenzl A; Gakis G
BJU Int; 2012 Dec; 110(11 Pt B):E533-40. PubMed ID: 22578156
[TBL] [Abstract][Full Text] [Related]
10. Impact of pretreatment thrombocytosis on survival in primary breast cancer.
Taucher S; Salat A; Gnant M; Kwasny W; Mlineritsch B; Menzel RC; Schmid M; Smola MG; Stierer M; Tausch C; Galid A; Steger G; Jakesz R;
Thromb Haemost; 2003 Jun; 89(6):1098-106. PubMed ID: 12783124
[TBL] [Abstract][Full Text] [Related]
11. [The occurrence and impact on survival of type 2 diabetes mellitus and thrombocytosis in colorectal cancer, before and after the surgical resection of the primary tumor].
Herold Z; Ambrus V; Herold M; Herczeg G; Igaz P; Harsányi L; Somogyi A
Orv Hetil; 2018 May; 159(19):756-767. PubMed ID: 29730943
[TBL] [Abstract][Full Text] [Related]
12. Inflammation-based prognostic system predicts postoperative survival of colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen.
Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Kubota K
Ann Surg Oncol; 2012 Oct; 19(11):3422-31. PubMed ID: 22576063
[TBL] [Abstract][Full Text] [Related]
13. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
Song A; Eo W; Lee S
World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
[TBL] [Abstract][Full Text] [Related]
14. Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients.
Feng Z; Wen H; Bi R; Duan Y; Yang W; Wu X
BMC Cancer; 2016 Jan; 16():43. PubMed ID: 26817451
[TBL] [Abstract][Full Text] [Related]
15. Is there a role for pre-operative thrombocytosis in the management of colorectal cancer?
Nyasavajjala SM; Runau F; Datta S; Annette H; Shaw AG; Lund JN
Int J Surg; 2010; 8(6):436-8. PubMed ID: 20685408
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancer.
Chadha AS; Kocak-Uzel E; Das P; Minsky BD; Delclos ME; Mahmood U; Guha S; Ahmad M; Varadhachary GR; Javle M; Katz MH; Fleming JB; Wolff RA; Crane CH; Krishnan S
Acta Oncol; 2015 Jul; 54(7):971-8. PubMed ID: 25608822
[TBL] [Abstract][Full Text] [Related]
17. Nomograms for predicting prognostic value of inflammatory biomarkers in colorectal cancer patients after radical resection.
Li Y; Jia H; Yu W; Xu Y; Li X; Li Q; Cai S
Int J Cancer; 2016 Jul; 139(1):220-31. PubMed ID: 26933932
[TBL] [Abstract][Full Text] [Related]
18. Elevated mean platelet volume predicts poor prognosis in colorectal cancer.
Li N; Yu Z; Zhang X; Liu T; Sun YX; Wang RT; Yu KJ
Sci Rep; 2017 Aug; 7(1):10261. PubMed ID: 28860547
[TBL] [Abstract][Full Text] [Related]
19. The Prognostic Significance of Pretreatment Hematologic Parameters in Patients Undergoing Resection for Colorectal Cancer.
Kozak MM; von Eyben R; Pai JS; Anderson EM; Welton ML; Shelton AA; Kin C; Koong AC; Chang DT
Am J Clin Oncol; 2017 Aug; 40(4):405-412. PubMed ID: 25756348
[TBL] [Abstract][Full Text] [Related]
20. The preoperative platelet to lymphocyte ratio is a prognostic marker in patients with stage II colorectal cancer.
Ozawa T; Ishihara S; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Hata K; Kawai K; Nozawa H; Kazama S; Yamaguchi H; Sunami E; Kitayama J; Watanabe T
Int J Colorectal Dis; 2015 Sep; 30(9):1165-71. PubMed ID: 26049902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
